We are live on ! Find out more
Millennium Management

Millennium Management Portfolio holdings

AUM $240B
1-Year Est. Return 35.51%
 

Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.

This Fund
S&P 500
This Quarter Est. Return
-13.46%
1 Year Est. Return
+35.51%
3 Year Est. Return
+105.02%
5 Year Est. Return
+129.21%
10 Year Est. Return
+672.65%
AUM
$161B
AUM Growth
-$27.5B
Cap. Flow
+$7.94B
Cap. Flow %
4.93%
Top 10 Hldgs %
22.83%
Holding
7,971
New
1,144
Increased
2,588
Reduced
2,287
Closed
1,065

Top Sells

Rank Stock Value
1
CERN
Cerner Corp
CERN
+$517M
2
XOM icon
ExxonMobil
XOM
+$385M
3
CVE icon
Cenovus Energy
CVE
+$292M
4
PLAN
Anaplan, Inc.
PLAN
+$236M
5
PSX icon
Phillips 66
PSX
+$222M

Sector Composition

Rank Sector Weight
1 Technology 7.76%
2 Financials 7.62%
3 Healthcare 7.1%
4 Industrials 5.08%
5 Consumer Discretionary 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LVACW
6651
CALL
DELISTED
LAVA Medtech Acquisition Corp. Warrants
LVACW
$9K ﹤0.01%
+77,500
New +$15.8K
IBER.WS
6652
CALL
DELISTED
Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
IBER.WS
$9K ﹤0.01%
+114,500
New +$19.8K
TZPSW
6653
CALL
DELISTED
TZP Strategies Acquisition Corp. Warrant
TZPSW
$9K ﹤0.01%
110,000
DRAYW
6654
CALL
DELISTED
Macondray Capital Acquisition Corp. I Warrant
DRAYW
$9K ﹤0.01%
90,833
KAIRW
6655
CALL
DELISTED
Kairos Acquisition Corp. Warrant
KAIRW
$9K ﹤0.01%
315,364
HCARW
6656
CALL
DELISTED
Healthcare Services Acquisition Corporation Warrant
HCARW
$9K ﹤0.01%
86,000
TSIBW
6657
CALL
DELISTED
Tishman Speyer Innovation Corp. II Warrant
TSIBW
$9K ﹤0.01%
71,633
-20,000
-22% -$5.46K
TLGA.WS
6658
CALL
DELISTED
TLG Acquisition One Corp. Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
TLGA.WS
$9K ﹤0.01%
115,833
BOAS.WS
6659
CALL
DELISTED
BOA Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at a price of $11.50 per share
BOAS.WS
$9K ﹤0.01%
54,332
RCHGW
6660
CALL
DELISTED
Recharge Acquisition Corp. Warrant
RCHGW
$9K ﹤0.01%
125,000
APRE icon
6661
Aprea Therapeutics
APRE
$8.05M
$8K ﹤0.01%
+513
New +$11.8K
BNZIW icon
6662
CALL
Banzai International Warrant
BNZIW
$8K ﹤0.01%
91,850
-1,150
-1% -$189
INUV icon
6663
Inuvo
INUV
$17M
$8K ﹤0.01%
+1,525
New +$6.79K
PALI icon
6664
Palisade Bio
PALI
$367M
$8K ﹤0.01%
+25
New +$12K
SLND.WS icon
6665
CALL
Southland Holdings Warrants
SLND.WS
$8K ﹤0.01%
30,000
BCSAW
6666
CALL
DELISTED
Blockchain Coinvestors Acquisition Corp. I Warrant
BCSAW
$8K ﹤0.01%
+101,650
New +$26K
LCW.WS
6667
CALL
DELISTED
Learn CW Investment Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
LCW.WS
$8K ﹤0.01%
100,000
TWLVW
6668
CALL
DELISTED
Twelve Seas Investment Company II Warrant
TWLVW
$8K ﹤0.01%
102,839
NSTB.WS
6669
CALL
DELISTED
Northern Star Investment Corp. II Redeemable warrants, each whole warrant exercisable for shares of Class A common stock at an exercise price of $11.50 per share
NSTB.WS
$8K ﹤0.01%
83,220
CFIVW
6670
CALL
DELISTED
CF Acquisition Corp. IV Warrant
CFIVW
$8K ﹤0.01%
86,741
SFRWW
6671
CALL
DELISTED
Appreciate Holdings, Inc. Warrant
SFRWW
$8K ﹤0.01%
75,000
-24,928
-25% -$5.96K
ATIP.WS
6672
CALL
DELISTED
ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
ATIP.WS
$8K ﹤0.01%
54,000
ORIAW
6673
CALL
DELISTED
Orion Biotech Opportunities Corp. Warrant
ORIAW
$8K ﹤0.01%
50,000
HTPA.WS
6674
CALL
DELISTED
Highland Transcend Partners I Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HTPA.WS
$8K ﹤0.01%
60,000
PHAS
6675
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$8K ﹤0.01%
13,501
-77,208
-85% -$73.9K

Similar funds

Millennium Management's Q2 2022 Portfolio in Review

As of Q2 2022, Millennium Management held 7,971 positions worth $161B, down 15% from $189B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Millennium Management deployed $7.94B of net new capital in Q2 2022, opening 1,144 new positions and adding to 2,588 existing holdings. Its largest new stake was M&T Bank: 828,809 shares worth $132M.

By sector, the portfolio is most concentrated in Technology at 7.8% of assets, up from 7.2% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was ExxonMobil, an estimated $385M trimmed.

  • Millennium Management's largest Q2 2022 buy was M&T Bank: 828,809 shares worth $132M.
  • Millennium Management added most to Invesco QQQ Trust in Q2 2022, an estimated $517M increase.
  • Millennium Management's biggest Q2 2022 reduction was ExxonMobil, cutting an estimated $385M.
  • Millennium Management fully exited Cerner Corp in Q2 2022, selling an estimated $517M.
  • Millennium Management's ten largest holdings make up 23% of its $161B portfolio in Q2 2022.
  • Millennium Management opened 1,144 new positions and closed 1,065 in Q2 2022.
  • Millennium Management's portfolio value fell 15% quarter-over-quarter to $161B.

Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.